Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF — Stella

Home/Hepatitis B/Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

View on ClinicalTrials.gov

Recruiting

Back to Hepatitis B trials

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong

Key details

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University

Enrollment target

~150 participants

Started

February 2019

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

12 Years – 65 Years

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.